
Natus Medical Incorporated NTUS
Quartalsbericht 2022-Q1
hinzugefügt 23.12.2023
Natus Medical Incorporated EV/EBITDA 2011-2026 | NTUS
EV/EBITDA Jährlich Natus Medical Incorporated
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 16.2 | -682 | 24 | 31.2 | 37.8 | 17.8 | 16.8 | 19.4 | 16.3 | 20.1 | 14.9 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 37.8 | -682 | -42.5 |
EV/EBITDA anderer Aktien in der Medizinische Geräte
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Bruker Corporation
BRKR
|
-2.13 | $ 36.73 | -0.1 % | $ 5.47 K | ||
|
Boston Scientific Corporation
BSX
|
25.2 | $ 62.21 | -0.97 % | $ 92.1 B | ||
|
AdaptHealth Corp.
AHCO
|
11 | $ 12.22 | 1.58 % | $ 1.65 B | ||
|
ClearPoint Neuro
CLPT
|
-9.73 | $ 9.4 | 0.32 % | $ 266 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
-244 | - | - | $ 1.77 B | ||
|
CONMED Corporation
CNMD
|
40.2 | $ 33.97 | -2.33 % | $ 1.05 B | ||
|
Apollo Endosurgery
APEN
|
-7.33 | - | - | $ 475 M | ||
|
Lianluo Smart Limited
LLIT
|
-50.1 | - | 24.59 % | $ 44.8 M | ||
|
Acutus Medical
AFIB
|
-0.915 | - | -26.83 % | $ 2.62 M | ||
|
Avinger
AVGR
|
-2.46 | - | -20.74 % | $ 369 K | ||
|
Cytosorbents Corporation
CTSO
|
-4.76 | $ 0.6 | 2.92 % | $ 37.3 M | ||
|
Axonics Modulation Technologies
AXNX
|
-36 | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
-4.45 | - | 1.37 % | $ 20.5 M | ||
|
Allied Healthcare Products
AHPI
|
367 | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
-4.23 | - | -5.86 % | $ 30.6 M | ||
|
Delcath Systems
DCTH
|
-1.69 | $ 9.73 | 1.04 % | $ 349 M | ||
|
BioSig Technologies
BSGM
|
-1.88 | - | 37.08 % | $ 85.7 M | ||
|
EDAP TMS S.A.
EDAP
|
730 | $ 3.48 | 2.66 % | $ 130 M | ||
|
Edwards Lifesciences Corporation
EW
|
39.2 | $ 80.91 | -0.17 % | $ 47.3 B | ||
|
Butterfly Network
BFLY
|
-3.9 | $ 4.14 | 0.73 % | $ 876 M | ||
|
FONAR Corporation
FONR
|
-33.4 | $ 18.59 | - | $ 122 M | ||
|
Cardiovascular Systems
CSII
|
-93.5 | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
236 | - | -10.19 % | $ 1.99 M | ||
|
AxoGen
AXGN
|
-19.1 | $ 32.92 | -4.41 % | $ 1.52 B | ||
|
Helius Medical Technologies
HSDT
|
-0.0925 | $ 1.97 | 5.91 % | $ 1.2 M | ||
|
CryoLife, Inc.
CRY
|
49.1 | - | -4.14 % | $ 702 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
29.6 | $ 9.28 | -2.62 % | $ 715 M | ||
|
Dynatronics Corporation
DYNT
|
-2.59 | - | 14.99 % | $ 929 K | ||
|
Inogen
INGN
|
17.4 | $ 6.42 | 3.3 % | $ 171 M | ||
|
Align Technology
ALGN
|
48.9 | $ 171.18 | 0.34 % | $ 12.8 B | ||
|
Eargo
EAR
|
-1.15 | - | - | $ 10.2 M | ||
|
IRIDEX Corporation
IRIX
|
-11.2 | $ 1.01 | 3.54 % | $ 17.1 M | ||
|
IRadimed Corporation
IRMD
|
46 | $ 96.42 | 0.2 % | $ 1.23 B | ||
|
Integer Holdings Corporation
ITGR
|
18.2 | $ 85.39 | -1.68 % | $ 2.97 B | ||
|
CHF Solutions, Inc.
CHFS
|
0.013 | - | 1.15 % | $ 34.5 M | ||
|
OrthoPediatrics Corp.
KIDS
|
-165 | $ 15.93 | -0.81 % | $ 374 M | ||
|
Soliton, Inc.
SOLY
|
-14 | - | -1.42 % | $ 435 M | ||
|
Conformis
CFMS
|
-44.1 | - | - | $ 16.4 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
90.3 | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
-38.6 | - | 0.03 % | $ 1.58 B | ||
|
LENSAR
LNSR
|
-1.48 | $ 5.93 | -2.23 % | $ 70.9 M | ||
|
Misonix, Inc.
MSON
|
-12 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
-20.2 | - | - | $ 111 M | ||
|
Pulmonx Corporation
LUNG
|
-22.5 | $ 1.39 | 4.51 % | $ 56.6 M | ||
|
Second Sight Medical Products
EYES
|
3.87 | - | -0.97 % | $ 54.4 M | ||
|
Medtronic PLC
MDT
|
24.4 | $ 86.32 | -0.36 % | $ 111 B | ||
|
MiMedx Group
MDXG
|
-669 | $ 3.91 | -0.38 % | $ 578 M | ||
|
Myomo
MYO
|
-2.96 | $ 0.69 | 3.25 % | $ 28.9 M | ||
|
Intersect ENT, Inc.
XENT
|
-12.1 | - | - | $ 955 M | ||
|
Orthofix Medical
OFIX
|
31.1 | $ 11.79 | 2.25 % | $ 467 M |